ArticleFrontiers in oncology2026
Demonstrating trends for early colorectal cancer incidence: a retrospective analysis of patients in Northwest Ohio.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colorectal cancer (CRC) is one of the most prevalent malignancies in the world and is the second leading cause of cancer mortality. Concerningly, CRC affecting patients aged 30-49 has been skyrocketing in recent decades, which has prompted adjustments to screening guidelines in the United States in 2023. With this single-center retrospective chart review, we evaluated 230 patients with CRC from the Northwest Ohio region with the goal of potentially identifying trends in demographic, lifestyle, and molecular risk factors in these patients. With this study, we believe that we have produced a data set that, while limited by a small early-onset cohort and unadjusted analyses, may be appropriate for use as a hypothesis-generating tool for future studies within the region in order to help direct further discussion regarding CRC in patients aged 30-49.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.